| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 324 |
| 1 | METHOTREXATE | 226 |
| 2 | PREDNISOLONE | 95 |
| 3 | PREDNISOLONE ORAL | 95 |
| 4 | PREDNISOLONE ORAL SOLUTION | 95 |
| 5 | TACROLIMUS | 58 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 56 |
| 7 | TACROLIMUS OINTMENT 0.1% | 56 |
| 8 | INFLIXIMAB | 51 |
| 9 | PREDNISONE | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 3 | 0.0031 |
| 1 | PURIXAN | 2 | 0.0026 |
| 2 | ROMIDEPSIN | 2 | 0.0012 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 4 | CLOFARABINE | 2 | 0.0009 |
| 5 | GOLIMUMAB | 10 | 0.0008 |
| 6 | MERCAPTOPURINE | 13 | 0.0007 |
| 7 | ADALIMUMAB-FKJP | 32 | 0.0007 |
| 8 | METHOTREXATE SODIUM | 324 | 0.0007 |
| 9 | ADALIMUMAB-AATY | 32 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 226 |
| 1 | Corticosteroid [EPC] | 160 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 84 |
| 3 | Purine Antimetabolite [EPC] | 41 |
| 4 | Alkylating Drug [EPC] | 30 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 6 | Topoisomerase Inhibitor [EPC] | 19 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 8 | Platinum-based Drug [EPC] | 13 |
| 9 | Vitamin B12 [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 226 | 0.0005 |
| 3 | Purine Antimetabolite [EPC] | 41 | 0.0004 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 5 | Topoisomerase Inhibitor [EPC] | 19 | 0.0002 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 7 | Corticosteroid [EPC] | 160 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 30 | 0.0001 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |